Evidence map›Paper›PMID 26912830›Full record

ArticleNucleic acids research2016

A phospho-dependent mechanism involving NCoR and KMT2D controls a permissive chromatin state at Notch target genes.

Franz Oswald, Patrick Rodriguez, Benedetto Daniele Giaimo, Zeus A Antonello, Laura Mira, Gerhard Mittler, Verena N Thiel, Kelly J Collins, Nassif Tabaja, Wiebke Cizelsky and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Set1 promotes Notch-induced transcriptional activation.Cellular and molecular life sciences : CMLS · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Franz OswaldUniversity Medical Center Ulm, Center for Internal Medicine, Department of Internal Medicine I, Albert-Einstein-Allee 23, 89081 Ulm, Germany franz.oswald@uni-ulm.de.
Patrick RodriguezSwiss Institute for Experimental Cancer Research, Lausanne, Switzerland.
Benedetto Daniele GiaimoInstitute of Biochemistry, University of Giessen, Friedrichstrasse 24, 35392 Giessen, Germany Spemann Graduate School of Biology and Medicine (SGBM), Faculty of Biology, Albert Ludwigs University Freiburg, Germany.
Zeus A AntonelloInstituto de Neurociencias, Consejo Superior de Investigaciones Cientificas-Universidad Miguel Hernández, Campus de Sant Joan, Alicante, Spain.
Laura MiraInstituto de Neurociencias, Consejo Superior de Investigaciones Cientificas-Universidad Miguel Hernández, Campus de Sant Joan, Alicante, Spain.
Gerhard MittlerMax-Planck-Institute of Immunobiology and Epigenetics, Stübeweg 51, 79108 Freiburg, Germany.
Verena N ThielUniversity Medical Center Ulm, Center for Internal Medicine, Department of Internal Medicine I, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
Kelly J CollinsDepartment of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH 45267, USA.
Nassif TabajaDepartment of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH 45267, USA.
Wiebke CizelskyInstitute for Biochemistry and Molecular Biology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany International Graduate School in Molecular Medicine Ulm (IGradU), Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
Melanie RotheInstitute for Biochemistry and Molecular Biology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany International Graduate School in Molecular Medicine Ulm (IGradU), Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
Susanne J KühlInstitute for Biochemistry and Molecular Biology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
Michael KühlInstitute for Biochemistry and Molecular Biology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany.
Francesca FerranteInstitute of Biochemistry, University of Giessen, Friedrichstrasse 24, 35392 Giessen, Germany.
Kerstin HeinInstitute of Biochemistry, University of Giessen, Friedrichstrasse 24, 35392 Giessen, Germany.
Rhett A KovallDepartment of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH 45267, USA.
Maria DominguezInstituto de Neurociencias, Consejo Superior de Investigaciones Cientificas-Universidad Miguel Hernández, Campus de Sant Joan, Alicante, Spain.
Tilman BorggrefeInstitute of Biochemistry, University of Giessen, Friedrichstrasse 24, 35392 Giessen, Germany Tilman.Borggrefe@biochemie.med.uni-giessen.de.
Universität Ulm · DEUniversity of Giessen · DEUniversity of Cincinnati · USConsejo Superior de Investigaciones Científicas · ESInstituto de Neurociencias · ESMax Planck Institute of Immunobiology and Epigenetics · DE

Funding

Training Program in Cancer TherapeuticsT32CA117846 · NCI · UNIVERSITY OF CINCINNATI · PI PRICE, CAROLYN M, TAKIAR, VINITA · 2006 to 2022
$6.5M
Molecular mechanisms of transcriptional regulation in the Notch pathwayR01CA178974 · NCI · UNIVERSITY OF CINCINNATI · PI KOVALL, RHETT ALLEN · 2013 to 2017
$1.6M
NCI NIH HHS R01 CA178974NCI NIH HHS T32 CA117846
6 · The paper itself

Abstract

The transcriptional shift from repression to activation of target genes is crucial for the fidelity of Notch responses through incompletely understood mechanisms that likely involve chromatin-based control. To activate silenced genes, repressive chromatin marks are removed and active marks must be acquired. Histone H3 lysine-4 (H3K4) demethylases are key chromatin modifiers that establish the repressive chromatin state at Notch target genes. However, the counteracting histone methyltransferase required for the active chromatin state remained elusive. Here, we show that the RBP-J interacting factor SHARP is not only able to interact with the NCoR corepressor complex, but also with the H3K4 methyltransferase KMT2D coactivator complex. KMT2D and NCoR compete for the C-terminal SPOC-domain of SHARP. We reveal that the SPOC-domain exclusively binds to phosphorylated NCoR. The balance between NCoR and KMT2D binding is shifted upon mutating the phosphorylation sites of NCoR or upon inhibition of the NCoR kinase CK2β. Furthermore, we show that the homologs of SHARP and KMT2D in Drosophila also physically interact and control Notch-mediated functions in vivo Together, our findings reveal how signaling can fine-tune a committed chromatin state by phosphorylation of a pivotal chromatin-modifier.

Indexed as

Gene Expression RegulationTranscription, GeneticAnimalsCasein Kinase IICell LineCell Line, TumorChromatinCo-Repressor ProteinsDNA-Binding ProteinsDrosophila ProteinsHistone CodeHistone-Lysine N-MethyltransferaseHomeodomain ProteinsHumansMiceMyeloid-Lymphoid Leukemia ProteinCasein Kinase IIChromatinCo-Repressor ProteinsDNA-Binding ProteinsDrosophila ProteinsHistone-Lysine N-MethyltransferaseHomeodomain ProteinsKmt2d protein, mouseMyeloid-Lymphoid Leukemia ProteinNuclear ProteinsReceptors, NotchRNA-Binding ProteinsSPEN protein, humanSpen protein, mouse

Identifiers

PMID26912830
PMCPMC4889922
OpenAlexW2292709386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.